Project Grant R21AI175964
- Federal Project Grant Award Summary Emory University received a $100,228 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 30, 2026, with a completion date of September 29, 2028. The award supports research investigating interactions of a conserved regulatory switch that controls physiology in spore-forming bacteria, specifically Bacilli and Clostridia species. The...
- This three-year Project Grant from the National Science Foundation's Division of Molecular and Cellular Biosciences totals $1,512,792 to fund research at Louisiana State University examining the gene regulatory networks affected by purine catabolites in bacterial pathogens. The research aims to identify additional transcription factors in Burkholderia thailandensis responsive to urate and xanthine, which accumulate in host tissues during infection due to production of reactive oxygen species....
- Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Ohio State University $775,022 on June 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct a five-year project investigating plasma membrane repair mechanisms in animal cells. The research focuses on understanding how cells rapidly reseal membrane damage caused by bacterial pore-forming toxins, specifically cholesterol-dependent cytolysins (CDCs) produced by major...
- This National Science Foundation (NSF) Project Grant award, funded under the Integrative Activities program (CFDA 47.083), supports research on the structural mechanisms of bacterial extracellular DNA-recognition. The $216,149 award to the Board of Regents of the University of Nebraska, from July 1, 2023 to June 30, 2026, aims to identify and characterize novel DNA receptor subunits incorporated into bacterial surface appendages. The project will purify soluble protein constructs, measure...
- Federal Project Grant Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Maryland, Baltimore $849,146 on September 9, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support research on the molecular mechanisms of anthrax toxin unfolding and translocation. The project, which extends through August 31, 2027, investigates how the bacterium Bacillus anthracis delivers its three-protein toxin—composed of protective...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Indiana University Trustees $428,857 on March 15, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to conduct fundamental research on cell dormancy and virus entrapment mechanisms. The project, extending through December 31, 2030, will advance understanding of host-virus coevolution by investigating how certain viruses exploit the dormancy programs of...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) awarded Columbia University $560,455 on February 4, 2026, for a five-year project (completion January 31, 2031) investigating the assembly and function of R-bodies in Pseudomonas aeruginosa. R-bodies are coiled protein structures that function as bacterial weapons against protists and contribute to virulence in this ESKAPE...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Boston College $426,250 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for a two-year project period from August 1, 2025, through July 31, 2027. The grant funds investigator-initiated biomedical research aimed at elucidating the function of two conserved peroxisome-derived proteins, PEX4 and PEX22, in apicomplexan parasite membrane transport and host cell...
- This National Science Foundation (NSF) Biological Sciences Program (CFDA 47.074) Project Grant award of $960,000 to The Ohio State University will fund a 3-year study to elucidate unique aspects of protein synthesis in the Bacteroidia, an important group of intestinal bacteria. The key objectives are to: (1) examine how the platform pocket formed by ribosomal proteins contributes to translation initiation in Flavobacterium johnsoniae, (2) determine the role of the novel ribosomal protein BL38 in...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded Trustees of Boston University $437,036 under the Biomedical Research and Research Training program (CFDA 93.859) to conduct fundamental research on bacterial glycoconjugate biosynthesis. The award, initiated June 1, 2026 and extending through May 31, 2031, funds genomic enzymology research to decipher bacterial membrane-associated glycan assembly mechanisms. The project focuses on identifying...
DESCRIBING THE STABLE, NON-COVALENT BCLA-BXPB ATTACHMENT IN B. ANTHRACIS SPORES - PROJECT SUMMARY BACILLUS ANTHRACIS IS A GRAM-POSITIVE SOIL BACTERIUM THAT FORMS SPORES WHEN STARVED FOR NUTRIENTS AND CONTACT WITH THESE SPORES CAUSES ANTHRAX IN ANIMALS AND HUMANS. B. ANTHRACIS SPORES ARE SURROUNDED BY THREE PROTECTIVE LAYERS, THE OUTERMOST OF WHICH IS A LOOSELY FITTING EXOSPORIUM. THE EXOSPORIUM PLAYS KEY ROLES IN SPORE SURVIVAL AND DISEASE PROGRESSION. OVER THE PAST TWO DECADES, THERE HAS BEEN SIGNIFICANT PROGRESS IN IDENTIFYING THE PROTEINS THAT COMPRISE THE EXOSPORIUM AND THEIR FUNCTIONS, HOWEVER, THE ASSEMBLY PROCESS IS POORLY UNDERSTOOD. THIS PROPOSAL IS DESIGNED TO ELUCIDATE MAJOR COMPONENTS OF EXOSPORIUM ASSEMBLY. THE EXOSPORIUM IS A BIPARTITE STRUCTURE CONSISTING OF A PARACRYSTALLINE BASAL LAYER AND AN EXTERNAL HAIR- LIKE NAP. EACH FILAMENT OF THE NAP IS FORMED SOLELY BY A TRIMER OF THE COLLAGEN-LIKE GLYCOPROTEIN BCLA. IN CONTRAST, THE BASAL LAYER CONTAINS ~25 DIFFERENT PROTEINS. ONE OF THESE PROTEINS CALLED BXPB IS REQUIRED FOR THE ATTACHMENT OF NEARLY ALL BCLA IN THE EXOSPORIUM. BCLA ATTACHMENT OCCURS THROUGH AND REQUIRES ONLY ITS 38- RESIDUE AMINO-TERMINAL DOMAIN (NTD), WHICH IS PROTEOLYTICALLY PROCESSED DURING SPORULATION TO REMOVE RESIDUES 1-19. CRYO-ELECTRON MICROGRAPHS REVEAL THAT EACH FILAMENT OF THE NAP-THROUGH BCLA RESIDUES 20-38-IS ATTACHED TO A BASAL LAYER SURFACE PROTRUSION THAT APPEARS TO BE A TRIMER OF BXPB. WHEN EXTRACTED FROM SPORES, BCLA AND BXPB ARE PRESENT PRIMARILY IN >250-KDA COMPLEXES, THE STABILITY OF WHICH SUGGESTED THAT THE TWO PROTEINS ARE ATTACHED THROUGH A COVALENT BOND. RECENT STUDIES FROM THIS LAB HAVE DEMONSTRATED THAT COMPLEXES BETWEEN PURIFIED BXPB AND BCLA RESIDUES 20-38, THAT ARE AS STABLE AS BCLA-BXPB COMPLEXES FOUND IN SPORES, CAN BE FORMED IN VITRO. THESE COMPLEXES DO NOT CONTAIN COVALENTLY CROSS-LINKED PEPTIDES, INDICATING THAT BCLA-BXPB ATTACHMENT IS NONCOVALENT. FURTHERMORE, WE RECENTLY DETERMINED THE CRYSTAL STRUCTURE OF BXPB TRIMERS, WITH MONOMERS THAT ARE ALL B-STRAND WITH CONNECTING LOOPS. THE ORIENTATION OF THREE OF THESE LOOPS SUGGEST THAT THEY CAN INTERACT WITH AND ENTRAP THE BCLA NTD. THE PRIMARY GOAL OF THIS STUDY IS TO USE STRUCTURAL AND GENETIC METHODS TO DESCRIBE THE AMINO ACID CONTACTS THAT ACCOUNT FOR THE STABLE BCLA-BXPB ATTACHMENT. STRUCTURAL TOOLS INCLUDE X-RAY CRYSTALLOGRAPHY, FOCUSING ON A BCLA NTD-BXPB COMPLEX, AND HYDROGEN DEUTERIUM EXCHANGE BY MASS SPECTROMETRY TO REVEAL CONTACTS BETWEEN THE BCLA NTD AND BXPB IN SOLUTION. TARGETED MUTAGENESIS OF BXPB AND THE BCLA NTD WILL REVEAL SPECIFIC ROLES FOR INDIVIDUAL AMINO ACIDS IN THE ATTACHMENT PROCESS. RELATED STUDIES WILL EXAMINE THE MECHANISM OF BXPB ATTACHMENT TO AND STABILIZATION OF THE BASAL LAYER SCAFFOLD AND THE REQUIREMENT FOR BCLA NTD CLEAVAGE IN BCLA-BXPB COMPLEX FORMATION. THE EXPECTED OUTCOME IS A DETAILED MODEL FOR BCLA-BXPB ATTACHMENT AND INSERTION INTO THE EXOSPORIUM. THIS STUDY WILL FURTHER IMPACT THE FIELD AS THIS MODEL IS LIKELY TO BE SHARED BY MANY OTHER SPORE-FORMING BACTERIA, INCLUDING IMPORTANT BACILLUS AND CLOSTRIDIUM PATHOGENS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 2/27/26 | ||
| Not listed | $180.1k | 2/20/25 | ||
| Not listed | $22.3k | 9/11/24 | ||
| Not listed | $22.3k | 9/11/24 | ||
| Not listed | $200.5k | 5/14/24 |